The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Chowdhury, Rasheduzzaman, Yeoh, Kar Kheng, Tian, Ya‐Min, Hillringhaus, Lars, Bagg, Eleanor A, Rose, Nathan R, Leung, Ivanhoe K H, Li, Xuan S +10 more·2011·The EMBO Reports

DOI 10.1038/embor.2011.43

Cited by (1,000)

Items 701–800 of 1,000

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
Jessica Petiti, Valentina Rosso, Eleonora Croce, Vanessa Franceschi, Giacomo Andreani, Matteo Dragani, Marco De Gobbi, Monia Lunghi, Giuseppe Nicola Saglio, Carmen Fava et al. · 2020 · Journal of Clinical Medicine
Something Old and Something New About Molecular Diagnostics in Gliomas
Craig Horbinski · 2012 · Surgical pathology clinics
The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches
Emily Gruber, Lev M. Kats · 2023 · Biochemical Society Transactions
Insights into novel emerging epigenetic drugs in myeloid malignancies
Namrata S. Chandhok, Thomas Prébet · 2019 · Therapeutic Advances in Hematology
Mitochondrial superoxide targets energy metabolism to modulate epigenetic regulation of NRF2-mediated transcription
Sanjit Kumar Dhar, Timothy L. Scott, Chi Wang, Teresa W.‐M. Fan, Daret K. St. Clair · 2021 · Free Radical Biology and Medicine
The chemistry and biology of the α-ketoglutarate-dependent histone N ε -methyl-lysine demethylases
Weiping Zheng, Yajun Huang · 2014 · MedChemComm
IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma
Yong‐Gang Yao · 2014 · Medical Science Monitor
Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism
Sergei G. Tevosian, Hans K. Ghayee · 2018 · The Journal of Clinical Endocrinology & Metabolism
Enchondromatosis and Growth Plate Development
Hongyuan Zhang, Benjamin Aaron Alman · 2020 · Current Osteoporosis Reports
SIRT7–SREBP1 restrains cancer cell metabolic reprogramming by upregulating IDH1
Fengting Su, Xiaolong Tang, Li Guo, Andreas Koeberle, Baohua Liu · 2021 · Genome Instability & Disease
Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1
Yueying Yang, Ke Xiang, Dejuan Sun, Mengzhu Zheng, Zhuorui Song, Mingxue Li, Xuanbin Wang, Hua Li, Lixia Chen · 2021 · Bioorganic & Medicinal Chemistry
The Crucial Roles of Intermediate Metabolites in Cancer
Sisi Huang, Zhiqin Wang, Liang Zhao · 2021 · Cancer Management and Research
Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas
Nikolaus von Knebel Doeberitz, Daniel Paech, Dominik Sturm, Stefan Pusch, Şevin Turcan, Yogen Saunthararajah · 2022 · International Journal of Cancer
Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5
Md. Saiful Islam, Marios S. Markoulides, Rasheduzzaman Chowdhury, Christopher John Schofield · 2022 · Scientific Reports
Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
Siva Kumar Natarajan, Matthew J Pun, James Haggerty-Skeans, Sriram Venneti · 2025 · Annual Review of Pathology Mechanisms of Disease
Organization of the Respiratory Supercomplexes in Cells with Defective Complex III: Structural Features and Metabolic Consequences
Michela Rugolo, Claudia Zanna, Anna Maria Ghelli · 2021 · Life
Blockage of L2HGDH-mediated S-2HG catabolism orchestrates macrophage polarization to elicit antitumor immunity
Shuang Feng, Duowei Wang, Yanyan Jin, Shi Huang, Tong Liang, Wei Sun, Xiuli Du, Luoyi Zhuo, Chun Shan, Wenbo Zhang et al. · 2024 · Cell Reports
Replenishment of TCA cycle intermediates and long-noncoding RNAs regulation in breast cancer
Xuewei Zheng, Shunshun Zhang, Haodi Ma, Yirui Dong, Jiayu Zheng, Li Zeng, Jiangbo Liu, Yanzhenzi Dai, Qinan Yin · 2024 · Molecular and Cellular Endocrinology
Targeting the Mitochondria in High-Grade Gliomas
Shaunak Sathe, Qi Li, Jinkyu Jung, Jing Wu · 2025 · Cancers
The role and regulatory mechanisms of the TCA cycle in early embryonic development
Yipan Lai, Xiurong Gao, Liwen Zhao, Jin Liu, Chao Gao, Qingfu Yan, Yangneng Zeng, Zibing Liao, Jianing Zhong · 2025 · Frontiers in Cell and Developmental Biology
The Role of 2-Oxoglutarate-Dependent Oxygenases in Hypoxia Sensing
Sarah E. Wilkins, Emily Flashman, John S. Scotti, Richard J. Hopkinson, Rasheduzzaman Chowdhury, Christopher John Schofield · 2015 · Royal Society of Chemistry eBooks
The epigenetic–metabolic interplay in gliomagenesis
Bismi Phasaludeen, Bright Starling Emerald, Suraiya Anjum Ansari · 2022 · Open Biology
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling
Xinbei Tian, Ying Wang, Ying Lu, Bo Ying Wu, Shanshan Chen, Jun Cheng Du, Wei Cai, Yongtao Xiao · 2022 · Cell Death and Disease
Using NMR to Monitor TET-Dependent Methylcytosine Dioxygenase Activity and Regulation
Colton J. Treadway, Joshua A. Boyer, Shiyue Yang, Hui Yang, Mengxi Liu, Zhijun Li, Meng Cheng, William F. Marzluff, Dan Ye, Yue Xiong et al. · 2024 · ACS Chemical Biology
Epigenomic Consequences of Coding and Noncoding Driver Mutations
Xiaosai Yao, Manjie Xing, Wen Fong Ooi, Patrick B. O. Tan, Bin Tean Teh · 2016 · Trends in cancer
Control of Ribosomal RNA Transcription by Nutrients
Yuji Tanaka, Makoto Tsuneoka · 2018 · InTech eBooks
Biochemical control systems for small molecule damage in plants
Meike Hüdig, J. Schmitz, Martin K. M. Engqvist, Verónica Graciela Maurino · 2018 · Plant Signaling & Behavior
(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia
Jeffrey R. Idle, Katja Seipel, Ulrike Bacher, Thomas Pabst, Diren Beyoğlu · 2020 · Cancers
Inhibition of JMJD6 by 2‐Oxoglutarate Mimics
Md. Sailful Islam, Cyrille C. Thinnes, James P. Holt‐Martyn, Rasheduzzaman Chowdhury, M.A. McDonough, Christopher John Schofield · 2021 · ChemMedChem
Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis
Nazareno González, Antonela Sofía Asad, José Gómez Escalante, Jorge Armando Pena Agudelo, Alejandro J. Nicola Candia, Matías Garcia Fallit, Adriana Seilicovich, Marianela Candolfi · 2021 · Expert Opinion on Therapeutic Targets
Beyond Isocitrate Dehydrogenase Mutations: Emerging Mechanisms for the Accumulation of the Oncometabolite 2-Hydroxyglutarate
Shufen Peng, Huimin Chen, Li Chen, Guang Yang, Jingjing Liu, Xueer Cheng, Yuhan Tang · 2022 · Chemical Research in Toxicology
Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia
Yu Yan, Ram Upadhyaya, Vivian Weixuan Zhang, Tobias Berg · 2022 · Experimental Hematology
Effects of deranged metabolism on epigenetic changes in cancer
Vishal Chandra, Kyeong‐Man Hong · 2015 · Archives of Pharmacal Research
Measurement of Oncometabolites d-2-Hydroxyglutaric Acid and l-2-Hydroxyglutaric Acid
Patricia M. Jones, Richard L. Boriack, Eduard A. Struys, Dinesh Rakheja · 2017 · Methods in molecular biology
The Molecular Basis of Histone Demethylation
John R. Horton, Molly Gale, Qin Yan, Xiaodong Cheng · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
The Role of Histone Methylation and Methyltransferases in Gene Regulation
Julia Yue Cui, Zidong Donna Fu, Joseph L. Dempsey · 2018 · Elsevier eBooks
Cancer-associated isocitrate dehydrogenase mutations induce mitochondrial DNA instability
Joanne M. Kingsbury, Nachiketha Shamaprasad, R. Blake Billmyre, Joseph Heitman, Maria Elena Cardenas · 2016 · Human Molecular Genetics
DeepMethylation: a deep learning based framework with GloVe and Transformer encoder for DNA methylation prediction
Zhe Wang, Sen Xiang, Chao Zhou, Qing Xu · 2023 · PeerJ
Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance
Enol Álvarez-González, Luisa María Sierra · 2024 · International Journal of Molecular Sciences
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
Lijuan Hu, Xudong Wei, Weili Zhao, Yu Hu, Juan Li, Yugang Dong, Tiejun Gong, Xuhan Zhang, Yajing Xu, Yu Zhang et al. · 2025 · Med
Mechanism analysis and targeted therapy of IDH gene mutation in glioma
Xingyuan Ma · 2025 · American Journal of Cancer Research
Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies
Xiao Lu, Shoujia Xu, Zhe Deng, Minjun Wang, Fei Chen · 2025 · Precision Clinical Medicine
Evaluating ivosidenib for the treatment of acute myeloid leukemia
Marjolein L. Donker, Gert Jan Ossenkoppele · 2020 · Expert Opinion on Pharmacotherapy
Epigenetics of Glioblastoma Multiforme
2015 · Journal of Clinical Research & Bioethics
Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures
Gokula Krishnan Ramachandran, Chen‐Hua Yeow · 2017 · Biological Research
Chemical individuality in T cells: A Garrodian view of immunometabolism
Peter J. McGuire · 2020 · Immunological Reviews
The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ)
Weilu Kuang, Wuzhong Jiang, Yinyun Chen, Yifu Tian, Zhengzheng Liu · 2021 · Cancer Biology & Therapy
Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology
Abraham Tsitlakidis, Anastasia Tsingotjidou, Aristeidis Κritis, Angeliki Cheva, Panagiotis Selviaridis, Elias C. Aifantis, Nikolaos Foroglou · 2021 · Cancers
Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2
Xiao Liu, Raphael Reinbold, Shuang Liu, Ryan A. Herold, Patrick Rabe, Stéphanie Duclos, Rahul B. Yadav, Martine I. Abboud, Sandrine Thieffine, Fraser Andrew Armstrong et al. · 2023 · Journal of Biological Chemistry
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives
Ugo Chianese, Chiara Papulino, Wout Megchelenbrink, Francesco Paolo Tambaro, Fortunato Ciardiello, Rosaria Benedetti, Lucia Altucci · 2023 · Seminars in Cancer Biology
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
Raffaela S. Berger, Christian J. Wachsmuth, Magdalena C. Waldhier, Kathrin Renner, Simone Thomas, Anuhar Chaturvedi, Hans-Helmut Niller, Elisabeth Bumes, Peter Hau, Martin Andreas Proescholdt et al. · 2021 · Cancers
2-Hydroxyglutarate modulates histone methylation at specific loci and alters gene expression via Rph1 inhibition
Marios Gavriil, Marco Proietto, Nicole Paczia, Aurélien Ginolhac, Rashi Halder, Elena Valceschini, Thomas Sauter, Carole L. Linster, Lasse Sinkkonen · 2023 · Life Science Alliance
Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis
Xiujie Li-Harms, Jingjun Lü, Yu Fukuda, John Lynch, Aditya Sheth, Gautam Pareek, Marcin M. Kamiński, Hailey S Ross, Christopher W. Wright, Amber L. Smith et al. · 2025 · Science Advances
IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
Alexander Bray, Vaibhav Sahai · 2025 · Current Oncology
Targeting of Mutant Isocitrate Dehydrogenase in Glioma: A Systematic Review
Tyler Ashford Lanman, L. Nicolas Gonzalez Castro · 2025 · Cancers
Immunometabolites and cancer: the role of 2-hydroxyglutarate, succinate, fumarate and itaconate in tumour development and anti-tumour immunity
Thomas Pfefer, Anna Hanga Bessenyei, Luke A.J. O'Neill · 2026 · Immunology Letters
Role of Additional Novel Therapies in Myeloproliferative Neoplasms
Warren C. Fiskus, Siddhartha Ganguly, Suman Kambhampati, Kapil N. Bhalla · 2012 · Hematology/Oncology Clinics of North America
Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia
Qingyun Wei, Kun Yao, Jie Yang, Qian Zhou, Pengyu Liu, Jiao Chen, Haipeng Liu, Yisheng Lai, Peng Cao · 2023 · Journal of Medicinal Chemistry
Alternative oxidase blunts pseudohypoxia and photoreceptor degeneration due to RPE mitochondrial dysfunction
Ming Chen, Yekai Wang, Roopa Dalal, Jianhai Du, Douglas Vollrath · 2024 · Proceedings of the National Academy of Sciences
Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2
Fangying Wang, Zhuoling Li, Tao Zhang, Guoyi Yan, Mingxing Hu, Lifeng Zhao, Yinglan Zhao, Yuanwei Chen · 2017 · Chemical Biology & Drug Design
Differentiation of Cancer Stem Cells by Using Synthetic Small Molecules: Toward New Therapeutic Strategies against Therapy Resistance
Chloé Maucort, Audrey Di Giorgio, Stéphane Azoulay, Maria Duca · 2020 · ChemMedChem
3D-QSAR, molecular docking and molecular dynamics simulations study of 3-pyrimidin-4-yl-oxazolidin-2-one derivatives to explore the structure requirements of mutant IDH1 inhibitors
Kun Yao, Pengyu Liu, Haipeng Liu, Qingyun Wei, Jie Yang, Peng Cao, Yisheng Lai · 2019 · Journal of Molecular Structure
Acute Myeloid Leukemia
Fortina P, Londin E, Park JY, Kricka LJ · 2017 · Methods in molecular biology
Beyond the Oncogene Revolution: Four New Ways to Combat Cancer
Thorsten Berger, Mary E. Saunders, Tak W. Mak · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations
Weitong Zhang, Hailong Bai, Yifan Wang, Xiaorui Wang, Ruyi Jin, Hui Guo, Huanling Lai, Yuping Tang, Yuwei Wang · 2024 · Pharmaceuticals
Interplay between epigenetics and metabolism controls cancer stem cell plasticity
Jee-Eun Choi, Inwha Baek · 2024 · Frontiers in Epigenetics and Epigenomics
R -2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity
Florence Couteau, Laurence M. Gagné, Karine Boulay, Philippe Rousseau, Mélissa Carbonneau, Mary E. McQuaid, Jyoti Nanda Sharma, Christina Sawchyn, Erlinda Fernández, Dagmar Glatz et al. · 2025 · Nucleic Acids Research
Metabo-epigenetic circuits of heart failure: chromatin-modifying enzymes as determinants of metabolic plasticity
Mark E. Pepin, Xuemin Gong, Almut Schulze, Johannes Backs · 2025 · EMBO Molecular Medicine
Transmembrane Amino Acid Transporters in Shaping the Metabolic Profile of Breast Cancer Cell Lines: The Focus on Molecular Biological Subtype
Elena I. Dyachenko, Lyudmila Vladimirovna Bel’skaya · 2024 · Current Issues in Molecular Biology
One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg‐Wiklund · 2021 · Epigenomes
Oncometabolites as Regulators of DNA Damage Response and Repair
Susan E. Gueble, Ranjit S. Bindra · 2021 · Seminars in Radiation Oncology
Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation
Ashraf Duzan, Desiree N. Reinken, Timothy L. McGomery, Nicholas M. Ferencz, Jacob M. Plummer, Mufeed M. Basti · 2023 · Journal of Chinese Integrative Medicine
Mutant Isocitrate Dehydrogenase 1 Expression Enhances Response of Gliomas to the Histone Deacetylase Inhibitor Belinostat
Chi-Ming Chang, Karthik K. Ramesh, Vicki Huang, Saumya S. Gurbani, Lawrence Richard Kleinberg, Brent D. Weinberg, Hyunsuk Shim, Hui‐Kuo G. Shu · 2023 · Tomography
Advances in molecular and imaging biomarkers in lower-grade gliomas
Alberto Pïcca, Francesco Bruno, Lucia Nichelli, Marc Sanson, Roberta Rudà · 2023 · Expert Review of Neurotherapeutics
Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma
Keisuke Miyake, Yoshifumi Baba, Takatsugu Ishimoto, Yukiharu Hiyoshi, Masaaki Iwatsuki, Yuji Miyamoto, Naoya Yoshida, Masayuki Watanabe, Yoko Ogata, Megumi Nagayama et al. · 2018 · Medical Oncology
IDH-Mutant Gliomas
Kensuke Tateishi, Tetsuya Yamamoto · 2019 · IntechOpen eBooks
Discovery of a Novel Chemical Scaffold Against Mutant Isocitrate Dehydrogenase 1 (IDH1)
Chung Hyo Kang, Sang Un Choi, You Hwa Son, Heung Kyoung Lee, Hye Gwang Jeong, Chang‐Soo Yun, Sunjoo Ahn, Chi Hoon Park · 2020 · Anticancer Research
Hypoxia-inducible factor 1α is required to establish the larval glycolytic program in Drosophila melanogaster
Yasaman Heidarian, Tess D. Fasteen, Liam Mungcal, Kasun Buddika, Nader H. Mahmoudzadeh, Travis G. Nemkov, Angelo D’Alessandro, Jason M. Tennessen · 2025 · Molecular Metabolism
IDH mutant high-grade gliomas
Santosh Valvi, Maryam Fouladi, Michael J. Fisher, Nicholas G. Gottardo · 2025 · Frontiers in Molecular Neuroscience
Profiling Inhibitor Scaffolds for the Cancer Target Jumonji‐C Domain‐Containing Protein 6
Thomas P. Corner, E. Salah, Anthony Tumber, James P. Holt‐Martyn, Lennart Brewitz, Christopher John Schofield · 2025 · ChemMedChem
New and Emerging Therapies for Patients with Low-Grade Glioma
Katherine B. Peters · 2025 · CNS Drugs
Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1 -mutated acute myeloid leukemia
Eunice S. Wang, Harry Paul Erba, Amer Methqal Zeidan, Gail J. Roboz, Jessica Kaplan Altman, Anjali S. Advani, Tara L. Lin, Stephen Anthony Strickland, Mark Juckett, Keith William Pratz et al. · 2026 · Blood
Insights into The Function and Regulation of Jumonji C Lysine Demethylases as Hypoxic Responsive Enzymes
Anand Chopra, Hemanta Adhikary, William Glen Willmore, Kyle K. Biggar · 2019 · Current Protein and Peptide Science
DNA inhibitors for the treatment of brain tumors
Lucia Lisi, Marta Chiavari, Gabriella Maria Pia Ciotti, Pedro Miguel Lacal, Pierluigi Navarra, Grazia Graziani · 2020 · Expert Opinion on Drug Metabolism & Toxicology
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors
Susan E. Gueble, Juan C. Vasquez, Ranjit S. Bindra · 2022 · Current Treatment Options in Oncology
Roles of the oncometabolite enantiomers of 2-hydroxyglutarate and their metabolism by diverse dehydrogenases
Ivelitza Garcia, Kathleen A. Cornely, Celeste N. Peterson, Melanie Barker Berkmen · 2024 · Essays in Biochemistry
Regulatory variation: an emerging vantage point for cancer biology
Luolan Li, Alireza Lorzadeh, Martin Hirst · 2013 · WIREs Systems Biology and Medicine
Acute exposure to an electric field induces changes in human plasma 9-HODE, 13-HODE, and immunoreactive substance P levels: Insight into the molecular mechanisms of electric field therapy
Yuzo Nakagawa-Yagi, Hiroyuki Hara, Fumiyuki Nakagawa, Masashi Sato, Akikuni Hara · 2016 · Integrative Molecular Medicine
Current and future tools for determination and monitoring of isocitrate dehydrogenase status in gliomas
Alberto Pïcca, Anna Luisa Di Stefano, Marc Sanson · 2018 · Current Opinion in Neurology
Sample Volume Reduction Using the Schwarzschild Objective for a Circular Dichroism Spectrophotometer and an Application to the Structural Analysis of Lysine-36 Trimethylated Histone H3 Protein
Yudai Izumi, Koichi Matsuo · 2018 · Molecules
IDH1 Expression via the R132H Mutation–Specific Antibody in Adrenocortical Neoplasias—Prognostic Impact in Carcinomas
Mirkka Pennanen, Olli Tynninen, Soili I. Kytölä, Pekka Ellonen, Harri K. Mustonen, Ilkka Heiskanen, Caj H. Haglund, Johanna T. Arola · 2020 · Journal of the Endocrine Society
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML
Molly C. Kingsley, Hongbo Michael Xie, Bo-Rui Chen, Simone Stefanie Riedel, Taylor Pastuer, Madelyn K. Bollig, Tyler Shank, Clara Libbrecht, Sally P. Stabler, Aniruddha J. Deshpande et al. · 2020 · Blood Advances
Genetic approaches to understand cellular responses to oxygen availability
Brian M. Ortmann, James A. Nathan · 2021 · FEBS Journal
The Warburg Effect and Beyond: Metabolic Dependencies for Cancer Cells
David M. Hockenbery, Mark F Tom, Cori Abikoff, Daciana H. Margineantu · 2012 · Springer eBooks
Polystyrene nanoplastics reprogramed pulmonary metabolisms mediated by immune regulation of myeloid hypoxia-inducible factor 1α
Ziniu Wang, Junran Liu, Wei Ling Guo, Gang Tang, Meilin Lv, Yaquan Liu, Jiexia Cheng, Hua Qin, Yun Ding, Xinyue Yang et al. · 2025 · Environment International
Mitochondrial l-2-hydroxyglutarate is a physiological signalling metabolite
Ram Prosad Chakrabarty, Jonathan G. Van Vranken, Yuki Aoi, Taylor A. Poor, Gregory Scott McElroy, Karthik Vasan, Shimaa Hassan AbdelAziz Soliman, Marta Iwanaszko, Rogan A. Grant, Benjamin C. Howard et al. · 2026 · Nature
Renal L-2-hydroxyglutarate dehydrogenase activity promotes hypoxia tolerance and mitochondrial metabolism in Drosophila melanogaster
Nader H. Mahmoudzadeh, Yasaman Heidarian, Jason P. Tourigny, Alexander J. Fitt, Katherine Beebe, Hongde Li, Arthur Luhur, Kasun Buddika, Liam Mungcal, Anirban Kundu et al. · 2024 · Molecular Metabolism
A novel biomarker GATM suppresses proliferation and malignancy of cholangiocarcinoma cells by modulating the JNK/c-Jun signalling pathways
Yi Yu, Wei Gan, Jianping Xiong, Junhe Li · 2024 · Heliyon
Metabolism and therapeutic response in acute myeloid leukemia with IDH1/2 mutations
Ludovic Gabellier, Enzo Bosetta, Maël Heiblig, Jean‐Emmanuel Sarry · 2025 · Trends in cancer
L2HGDH Missense Variant in a Cat with L-2-Hydroxyglutaric Aciduria
Matthias Christen, Nils Janzen, Anne Fraser, A Sewell, Vidhya Jagannathan, Julien Guevar, Tosso Leeb, Daniel Sánchez‐Masián · 2021 · Genes